Antifungal Activity, Mode of Action, Docking Prediction and Anti-biofilm Effects of (+)-β-pinene Enantiomers against Candida spp.

被引:40
|
作者
de Macedo Andrade, Ana Claudia [1 ]
Rosalen, Pedro Luiz [2 ]
Freires, Irlan Almeida [3 ]
Scotti, Luciana [1 ]
Scotti, Marcus Tulius [1 ]
Aquino, Sabrina Garcia [1 ]
de Castro, Ricardo Dias [1 ]
机构
[1] Univ Fed Paraiba, Campus 1, Joao Pessoa, Paraiba, Brazil
[2] Univ Estadual Campinas, Piracicaba Dent Sch, Piracicaba, SP, Brazil
[3] Univ Florida, Coll Dent, Gainesville, FL USA
关键词
Candidiasis; Products with antimicrobial action; Antifungal agents; Drug synergism; Molecular docking simulation; ESSENTIAL OILS; ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION; ALBICANS; GROWTH; SUSCEPTIBILITY; CASPOFUNGIN; FLUCONAZOLE; INHIBITORS; TERPENES;
D O I
10.2174/1568026618666181115103104
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Aims: The objective of this study was to investigate the effectiveness of (+)-beta-pinene inhibition on Candida spp. growth, aiming at elucidation of the mechanism of action; to determine fungal cell enzyme binding activity (through molecular docking simulations) and its effects on biofilm reduction. Methods: Candida strains (n=25) from referenced and clinical origins, either susceptible or resistant to standard clinical antifungals, were tested for determination of Minimum Inhibitory Concentration (MIC); Minimum Fungicidal Concentration (MFC); and microbial death curves upon treatment with (+)-beta-pinene; the effects of (+)-beta-pinene on the cell wall (sorbitol assay), membrane ergosterol binding, and effects on biofilm were evaluated by microdilution techniques. We also evaluated the interactions between (+)-beta-pinene and cell wall and membrane enzymes of interest. Results: The MIC values of (+)-beta-pinene ranged from <56.25 to 1800 mu mol/L. The MIC of (+)-beta-pinene did not increase when ergosterol was added to the medium, however it did increase in the presence of sorbitol, leading to a doubled MIC for C. tropicalis and C. krusei. The results of the molecular docking simulations indicated better interaction with delta-14-sterol reductase (-51kcal/mol). (+)-beta-pinene presents anti-biofilm activity against multiples species of Candida. Conclusion: (+)-beta-pinene has antifungal activity and most likely acts through interference with the cell wall; through molecular interaction with Delta-14-sterol reductase and, to a lesser extent, with the 1,3-beta-glucan synthase. This molecule was also found to effectively reduce Candida biofilm adhesion.
引用
收藏
页码:2481 / 2490
页数:10
相关论文
共 50 条
  • [1] Docking Prediction, Antifungal Activity, Anti-Biofilm Effects on Candida spp., and Toxicity against Human Cells of Cinnamaldehyde
    da Nobrega Alves, Danielle
    Monteiro, Alex France Messias
    Andrade, Patricia Neris
    Lazarini, Josy Goldoni
    Abilio, Gisely Maria Freire
    Guerra, Felipe Queiroga Sarmento
    Scotti, Marcus Tullius
    Scotti, Luciana
    Rosalen, Pedro Luiz
    de Castro, Ricardo Dias
    MOLECULES, 2020, 25 (24):
  • [2] Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp.
    Peixoto, Larissa Rangel
    Rosalen, Pedro Luiz
    Silva Ferreira, Gabriela Lacet
    Freires, Irian Almeida
    de Carvalho, Fabiola Galbiatti
    Castellano, Lucio Roberto
    de Castro, Ricardo Dias
    ARCHIVES OF ORAL BIOLOGY, 2017, 73 : 179 - 185
  • [3] α-Pinene: Docking Study, Cytotoxicity, Mechanism of Action, and Anti-Biofilm Effect against Candida albicans
    de Barros, Daniela Bomfim
    Lima, Luanna
    da Silva, Larissa Alves
    Fonseca, Mariana Cavalcante
    Ferreira, Rafael Carlos
    Neto, Hermes Diniz
    Alves, Danielle da Nobrega
    Rocha, Walicyranison Plinio da Silva
    Scotti, Luciana
    Lima, Edeltrudes de Oliveira
    Sobral, Marianna Vieira
    Castellano, Lucio Roberto Cancado
    Moura-Mendes, Juliana
    Guerra, Felipe Queiroga Sarmento
    da Silva, Marcia Vanusa
    ANTIBIOTICS-BASEL, 2023, 12 (03):
  • [4] Antifungal and anti-biofilm effects of hydrazone derivatives on Candida spp
    Popczyk, Pierre
    Ghinet, Alina
    Bortolus, Clovis
    Kamus, Laure
    Lensink, Marc F.
    de Ruyck, Jerome
    Sendid, Boualem
    Dubar, Faustine
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2024, 39 (01)
  • [5] Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates
    Roscetto, Emanuela
    Contursi, Patrizia
    Vollaro, Adriana
    Fusco, Salvatore
    Notomista, Eugenio
    Catania, Maria Rosaria
    SCIENTIFIC REPORTS, 2018, 8
  • [6] Antifungal and anti-biofilm activity of Dictyophora indusiata against Candida albicans
    Sritananuwat, Phaijit
    Prathumtet, Jatuporn
    Puapermpoonsiri, Utsana
    Kumlung, Tantima
    Rangsimawong, Worranan
    Duangjit, Sureewan
    MAEJO INTERNATIONAL JOURNAL OF SCIENCE AND TECHNOLOGY, 2023, 17 (03) : 228 - 238
  • [7] Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates
    Emanuela Roscetto
    Patrizia Contursi
    Adriana Vollaro
    Salvatore Fusco
    Eugenio Notomista
    Maria Rosaria Catania
    Scientific Reports, 8
  • [8] Antifungal and anti-biofilm activity of a new Spanish extract of propolis against Candida glabrata
    Fernandez-Calderon, Maria Coronada
    Hernandez-Gonzalez, Laura
    Gomez-Navia, Carolina
    Blanco-Blanco, Maria Teresa
    Sanchez-Silos, Rosa
    Lucio, Leopoldo
    Perez-Giraldo, Ciro
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2021, 21 (01)
  • [9] In vitro Antifungal Effects of Berberine Against Candida spp. In Planktonic and Biofilm Conditions
    Xie, Yufei
    Liu, Xiaosong
    Zhou, Peiru
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 87 - 101
  • [10] Antifungal and anti-biofilm activity of a new Spanish extract of propolis against Candida glabrata
    María Coronada Fernández-Calderón
    Laura Hernández-González
    Carolina Gómez-Navia
    María Teresa Blanco-Blanco
    Rosa Sánchez-Silos
    Leopoldo Lucio
    Ciro Pérez-Giraldo
    BMC Complementary Medicine and Therapies, 21